News - Vaccines


Current filters:


Popular Filters

176 to 200 of 258 results

PDUFA Action Date for Astellas enzalutamide; Urogenix facility to close


The US Food and Drug Administration has assigned a Prescription Drug User Fee Act (PDUFA) action date…

Astellas PharmaenzalutamideGenito-urinaryMedivationOncologyPharmaceuticalRegulationResearchUrogenixVaccines

Silencing investor concerns? Alnylam achieves RNAi milestone


US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) has received a $3.2 million milestone…

Alnylam PharmaceuticalsAnti-viralsBiotechnologyFinancialGlaxoSmithKlineLicensingProductionVaccines

UK to implement child flu vaccines program


UK Health Secretary Andrew Lansley yesterday accepted recommendations from UK immunization experts to…


Sanofi Pasteur's dengue vaccine proves effective and safe; FDA identifies cGMP deviations


French drug major Sanofi (Euronext: SAN) vaccines subsidiary Sanofi Pasteur sais this morning that its…

PharmaceuticalRegulationResearchSanofiSanofi PasteurTropical diseasesVaccines

Vivalis in new EB66 cell line deal with Merial


France-based Vivalis (NYSE Euronext: VLS) announced today that it has executed a new research license…


Sanofi Pasteur starts shipping Fluzone in USA for 2012-2013 flu season


The first lots of Fluzone vaccine have began shipping to US health care providers following Food and…

Anti-viralsFluzoneMarkets & MarketingNorth AmericaPharmaceuticalSanofiSanofi PasteurVaccines

Novavax and Cadila in public/private malaria vaccine collaboration


USA-based clinical-stage firm Novavax (Nasdaq: NVAX), CPL Biologicals (CPLB) - a joint-venture biotechnology…

Cadila PharmaceuticalsCPL BiologicalsNovavaxPharmaceuticalResearchTropical diseasesVaccines

Australia extends HPV vaccine to schoolboys


In what is claimed "a world first" by the Department of Health and Ageing, Australian schoolboys will…

Asia-PacificGardasilHealthcareMerck & CoOncologyPharmaceuticalVaccines

Single silk device can store and deliver vaccine or antibiotic without costly cold chain


Researchers at the USA-based Tufts University School of Engineering have discovered a way to maintain…

Antibiotics and Infectious diseasesPharmaceuticalResearchVaccines

New vaccine uptake drives market growth in India


In India, the government-sponsored Universal Immunization Program procures vaccines at very low prices,…

Asia-PacificMarkets & MarketingPharmaceuticalVaccines

Bilthoven Biologicals acquired by Serum Institute of India


Bilthoven Biologicals, a Dutch manufacturer of monoclonal antibodies and vaccines, said this week that…

Bilthoven BiologicalsBiotechnologyMergers & AcquisitionsPharmaceuticalSerum Institute of IndiaVaccines

CSL Biotherapies indentifies likely reason for Fluvax problems


Australia's largest biotech firm CSL Biotherapies, a division of CSL Limited (ASX: CSL) today presented…

Asia-PacificBiotechnologyCSL BiotherapiesCSL LimitedFluvaxMarkets & MarketingVaccines

Batch of mixed opinions from FDA advisory panels


Advisory panels of the US Food and Drug Administration meeting yesterday came back with a mixture of…

carfilzomibKyprolisMerck & CoNorth AmericaOncologyOnyx PharmaceuticalsPfizerPharmaceuticalPneumovaxPrevnarRegulationSanofisemuloparinVaccines

US HHS creates new centers to develop, manufacture medical countermeasures


The US Department of Health and Human Services this week established three new centers to develop and…

GlaxoSmithKlineHealthcareNorth AmericaNovartisPharmaceuticalResearchVaccines

FDA approves GlaxoSmithKline's new combo vaccine MenHibrix


The US Food and Drug Administration has approved US pharma giant GlaxoSmithKline's (LSE: GSK) MenHibrix…

GlaxoSmithKlineMenHibrixNorth AmericaPharmaceuticalRegulationVaccines

OPKO Health to acquire 45% stake in Israeli hepatitis B vaccine maker


Miami, USA-based OPKO Health (NYSE: OPK) has entered into a definitive agreement to acquire a 45% stake…

FDS PharmaMergers & AcquisitionsOPKO HealthPharmaceuticalSci-B-VacSciGenVaccines

GlaxoSmithKline plans vaccines and cancer drugs production in Kazakhstan


UK pharma giant GlaxoSmithKline (LSE: GSK) has signed a cooperation agreement with the government of…

EuropeGlaxoSmithKlineMarkets & MarketingOncologyPharmaceuticalVaccines

AFFiRiS starts first clinical trial with Parkinson's vaccine candidate PD01A


The worldwide first clinical trial for the development of a Parkinson's vaccine has now been started…


US government adds $32 million to Bavarian Nordic Imvamune contract


Denmark's Bavarian Nordic (Nasdaq OMX: BAVA) says that the US Department of Health and Human Services…

Bavarian NordicFinancialImvamuneNorth AmericaPharmaceuticalResearchVaccines

New Global Vaccine Action Plan does not go far enough, says MSF


A new, 10-year, multi-billion dollar action plan for global vaccination may fail to deliver if it does…


Biovest to file for EU approval of BiovaxID, a personalized cancer vaccine


USA-based Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

BiovaxIDBiovest InternationalEuropeOncologyPharmaceuticalRegulationVaccines

EU Commission clears 23 million-euro R&D aid to Novartis Italy for vaccines in developing countries


The European Commission has concluded that 23 million euros ($30.2 million) public funding, which Italy…


Vaccines collaborations by Biovest and US Army and by ARTES and Crucell


USA-based Biovest International (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals…

ARTES BiotechnologyBiotechnologyBiovest InternationalCrucellJohnson & JohnsonResearchVaccines

176 to 200 of 258 results

Back to top